Ekterly 300 mg
Ekterly 300 mg is a medicine authorised by Swissmedic under authorisation number 69540. The authorisation holder is KalVista Pharmaceuticals Switzerland GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 17 September 2025 and the authorisation is limited until 16 September 2030. ATC code B06AC08 places the medicine in the group Other hematological agents.
| Authorisation number | 69540 |
|---|---|
| Name | Ekterly 300 mg |
| Full name | Ekterly 300 mg, Filmtabletten |
| Authorisation holder | KalVista Pharmaceuticals Switzerland GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | B06AC08 |
| First authorisation | 17 September 2025 |
| Authorisation validity | 16 September 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ekterly 300 mg, Filmtabletten | B | 17 September 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 4 | Tablette(n) | B06AC08 | 02.99.0. | B |
| 2 | 6 | Tablette(n) | B06AC08 | 02.99.0. | B |
Scroll the table sideways
Frequently asked questions
Is Ekterly 300 mg authorised in Switzerland?
Yes. Ekterly 300 mg is authorised by Swissmedic under authorisation number 69540, data as of 01 September 2026. The authorisation is limited until 16 September 2030.
Which dispensing category does Ekterly 300 mg have?
Ekterly 300 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ekterly 300 mg?
The authorisation holder is KalVista Pharmaceuticals Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.